Trogenix, a biotech company dedicated to developing cancer therapies, has completed its Series A financing, raising £70m (US$94m) led by IQ Capital with participation from founding investor 4BIO Capital, returning…
UK: Trogenix raises £70m Series A to enhance Odysseus
…
…






